Comparison of Tissue Retractors During Cesarean Delivery in Obese Women
Randomized Controlled Trial of the Efficacy of the Mobius ™ Retractor in Performing Cesarean Sections in Patients With BMI ≥35kg/m2
1 other identifier
interventional
60
1 country
1
Brief Summary
This is a randomized controlled trial comparing the use of the Mobius™ retractor to the use of traditional metal retraction instruments in non-urgent cesarean deliveries of obese women. The Mobius™ retractor was designed for abdominal surgery to improve visualization of the surgical field through standard surgical incisions and is now a standard instrument used for cesarean deliveries at Thomas Jefferson University Hospital. We hypothesize that the use of the Mobius™ retractor during cesarean deliveries in obese women decreases operative time, blood loss, number of transfusions, infectious morbidity, incision length, and intra- / post-operative antiemetic and pain medication use, while increasing surgeon satisfaction.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jul 2006
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 1, 2006
CompletedFirst Submitted
Initial submission to the registry
July 31, 2006
CompletedFirst Posted
Study publicly available on registry
August 1, 2006
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2014
CompletedMay 21, 2013
May 1, 2013
July 31, 2006
May 20, 2013
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
operative time
Secondary Outcomes (7)
blood loss
number of transfusions
infectious morbidity
incision length
intra and postoperative antiemetic medication use
- +2 more secondary outcomes
Interventions
Eligibility Criteria
You may qualify if:
- pregnant women undergoing non-urgent cesarean delivery
You may not qualify if:
- women undergoing urgent cesarean delivery
- BMI \<35kg/m2
- women undergoing vaginal delivery
- positive urine drug screen or known history of methadone maintenance or substance abuse
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Thomas Jefferson Universitylead
- Apple Medical Corporationcollaborator
Study Sites (1)
Thomas Jefferson University
Philadelphia, Pennsylvania, 19107, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Jason K Baxter, MD, MSCP
Thomas Jefferson University
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 31, 2006
First Posted
August 1, 2006
Study Start
July 1, 2006
Study Completion
June 1, 2014
Last Updated
May 21, 2013
Record last verified: 2013-05